Your browser doesn't support javascript.
loading
Exploring the untapped pharmacological potential of imidazopyridazines.
Malik, M Shaheer; Alshareef, Hossa F; Alfaidi, Khalid A; Ather, Hissana; Abduljaleel, Zainularifeen; Hussein, Essam M; Moussa, Ziad; Ahmed, Saleh A.
Afiliação
  • Malik MS; Department of Chemistry, Faculty of Science, Umm Al-Qura University Makkah 21955 Saudi Arabia.
  • Alshareef HF; Department of Chemistry, Faculty of Science, Umm Al-Qura University Makkah 21955 Saudi Arabia.
  • Alfaidi KA; Department of Chemistry, Faculty of Science, Umm Al-Qura University Makkah 21955 Saudi Arabia.
  • Ather H; Science and Technology Unit, Umm Al-Qura University Makkah 21955 Saudi Arabia.
  • Abduljaleel Z; Department of Pharmaceutical Chemistry, College of Pharmacy, King Khalid University (KKU) Abha 62529 Saudi Arabia.
  • Hussein EM; Department of Chemistry, Faculty of Science, Umm Al-Qura University Makkah 21955 Saudi Arabia.
  • Moussa Z; Department of Chemistry, Faculty of Science, Assiut University 71516 Assiut Egypt.
  • Ahmed SA; Department of Chemistry, College of Science, United Arab Emirates University P.O. Box 15551 Al Ain United Arab Emirates msmalik@uqu.edu.sa saahmed@uqu.edu.sa.
RSC Adv ; 14(6): 3972-3984, 2024 Jan 23.
Article em En | MEDLINE | ID: mdl-38288152
ABSTRACT
Imidazopyridazines are fused heterocycles, like purines, with a pyridazine ring replacing the pyrimidine ring in purines. Imidazopyridazines have been primarily studied for their kinase inhibition activity in the development of new anticancer and antimalarial agents. In addition to this, they have also been investigated for their anticonvulsant, antiallergic, antihistamine, antiviral, and antitubercular properties. Herein, we review the background and development of different imidazopyridazines as potential pharmacological agents. Moreover, the scope of this relatively less charted heterocyclic scaffold is also highlighted.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: RSC Adv Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: RSC Adv Ano de publicação: 2024 Tipo de documento: Article